logo
#

Latest news with #EastOfEngland

La Caisse commits to invest in Sizewell C, a critical asset for economic growth and energy security in the UK
La Caisse commits to invest in Sizewell C, a critical asset for economic growth and energy security in the UK

Globe and Mail

time2 days ago

  • Business
  • Globe and Mail

La Caisse commits to invest in Sizewell C, a critical asset for economic growth and energy security in the UK

MONTRÉAL and LONDON , July 22, 2025 /CNW/ - Quebec based global investment group, La Caisse (formerly CDPQ), today announces its commitment to invest up to £1.7 billion ( CAD 3.2 billion ) in Sizewell C, a 3.2GW nuclear power station located in the East of England . The investment, which represents a 20% stake in the project, will leverage La Caisse's proven track record in delivering large scale infrastructure projects globally and support the UK's transition to clean power and progress to net zero. Once complete, Sizewell C will provide over 60 years of clean, reliable power to the UK grid, helping to boost the UK's economy, strengthen energy security and help reduce reliance on hydrocarbon sources, avoiding 9 million tonnes of carbon emissions annually. The investment will be made alongside the UK Government, experienced operator EDF, British multinational energy and services company Centrica and investment partner Amber Infrastructure. The project is structured under the UK Government's Regulated Asset Base (RAB) model which helps fund large-scale projects by offering predictability to investors while ensuring value for consumers over the long term. "Our commitment to invest in Sizewell C reflects La Caisse's constructive capital approach, working to deliver optimal financial performance for our clients alongside broader economic and societal progress. La Caisse has a strong track record of bringing private sector expertise alongside governments and industrial players to invest in complex, regulated infrastructure where value-for-money for consumers is key. Sizewell C is a positive development for UK consumers, as it is expected to provide long-term reliable baseload power and low carbon energy to more than 6 million homes across the UK, while contributing to the creation of 10,000 new jobs at peak construction and thousands more in the nationwide supply chain. We're proud to support the UK Government in delivering this landmark project, advancing the country's energy security and economic growth ambitions. Our investment demonstrates our confidence in the UK market – our largest destination outside North America – and aligns with our commitment to the energy transition and decarbonization, enabled by our long-term capital and active ownership," said Emmanuel Jaclot, Executive Vice-President and Head of Infrastructure at La Caisse. "It is time to do big things and build big projects in this country again – and today we announce an investment that will provide clean, homegrown power to millions of homes for generations to come. This government is making the investment needed to deliver a new golden age of nuclear, so we can end delays and free us from the ravages of the global fossil fuel markets to bring bills down for good," said Secretary of State for Energy Security and Net Zero, Ed Miliband. "We're delighted to welcome La Caisse's investment in Sizewell C. Their decision to take a 20% stake in the project reflects growing international backing for UK nuclear and confidence in Sizewell C. As one of the world's leading institutional investors, La Caisse brings significant experience in sustainable infrastructure and in delivering projects that drive economic growth and long-term value creation. Their involvement reinforces our strong financial base and supports our mission to create tens of thousands of high-quality jobs and 1500 apprenticeships across the country. Sizewell C will boost energy security, cut carbon, and drive regional and national growth for decades to come, and we're proud to have La Caisse on board as part of that journey," said Julia Pyke and Nigel Cann , Joint Managing Directors of Sizewell C. La Caisse is the world's second largest institutional infrastructure investor, currently manages over £20 billion in UK investments and has significant experience in delivering projects that drive economic growth and positive change. La Caisse intends to invest around £8 billion in the UK over the next five years, increasing its asset allocation to the British market by nearly 50 percent. La Caisse has acted as a partner of trust and choice to the UK Government and its business partners for many years and has brought benefits to millions of UK consumers through investments in Eurostar, Heathrow Airport, First Hydro Company and London Array, an offshore wind farm generating 630MW of electricity, enough to power 500,000 UK homes. La Caisse is also deeply committed to sustainable investing and investments supporting climate action. The firm has recently committed to have nearly £220 billion ( CAD 400 billion ) invested globally by the end of the decade in companies committed to decarbonising their operations as well as in climate solutions. These investments align with La Caisse's commitment to its clients: delivering long-term value while managing risk responsibly. ABOUT LA CAISSE At La Caisse, formerly CDPQ, we have invested for 60 years with a dual mandate: generate optimal long-term returns for our 48 depositors, who represent over 6 million Quebecers, and contribute to Québec's economic development. As a global investment group, we are active in the major financial markets, private equity, infrastructure, real estate and private credit. As at December 31, 2024, La Caisse's net assets totalled CAD 473 billion. For more information, visit or consult our LinkedIn or Instagram pages. For more information

Fake Botox ‘poisoning cosmetic patients'
Fake Botox ‘poisoning cosmetic patients'

Telegraph

time6 days ago

  • Health
  • Telegraph

Fake Botox ‘poisoning cosmetic patients'

Thirty-eight people in the UK have been poisoned by fake Botox since last month, officials have revealed. Victims experienced difficulties with breathing and swallowing, as well as slurred speech, after suffering from botulism, a rare and life-threatening condition. The UK Healthcare Security Agency (UKHSA) issued a warning over the cases in the East of England and the East Midlands, following a spate of similar poisonings in the North East. To date, 38 cases of 'iatrogenic botulism' have been reported between 4 June and 14 July. The UKSHA said it was warning people to be aware of the symptoms after victims needed NHS care after suffering from adverse reactions. Evidence so far suggests that an 'unlicensed Botox-like product' had been used, the agency said. The practitioners involved have stopped offering the injections and are co-operating with an ongoing investigation, the UKSHA said. Officials said there were no known links between the newly diagnosed cases and those in the North East. Symptoms can take four weeks to develop The UKHSA has urged members of the public to make sure they take precautions when seeking aesthetic procedures, including checking if the product being used is licensed. Dr Gauri Godbole, a consultant medical microbiologist at the UKHSA, said: 'Botulism related to aesthetic procedures is rare, but it can be serious. It is caused by toxins produced by the bacterium Clostridium botulinum. These toxins (but not the bacteria) are the active ingredient in 'Botox' and similar products. 'Symptoms of botulism can take up to four weeks to develop, and if you have had a recent botulinum toxin (Botox-like) treatment and are having symptoms such as difficulty swallowing or breathing, contact NHS 111 for further advice and seek treatment.'

Patients in England's most deprived areas wait longer for NHS treatment, data reveals
Patients in England's most deprived areas wait longer for NHS treatment, data reveals

The Guardian

time7 days ago

  • Health
  • The Guardian

Patients in England's most deprived areas wait longer for NHS treatment, data reveals

Patients from the most deprived areas of England face longer waits for NHS treatment and make up a higher proportion of those waiting for care, according to figures. Data released by NHS England on Thursday provides a breakdown of the health service's waiting lists by ethnicity and deprivation levels for the first time. It shows that people in the most deprived areas of England and people from ethnic minority backgrounds make up a disproportionate and growing proportion of those waiting for NHS treatment. An average of 3.1% of patients living in the most deprived areas had been waiting more than a year to begin treatment as of June, compared with 2.7% of the least deprived. The deprivation gap is even wider in certain regions of England, with 2.4% of patients in the most deprived areas in London waiting over a year for treatment, compared with about 4.9% of the most deprived in the east of England. Patients from an Asian or British Asian background were more likely to be waiting longer than 18 weeks for treatment than any other group, and the east of England and south-west England were regions with the largest ethnicity gap for people waiting more than a year to begin hospital treatment. 60.3% of white British patients were seen within 18 weeks, compared with 57% of Bangladeshi patients, and 58.2% of Asian and British Asian groups overall. The data was released after the health secretary, Wes Streeting, unveiled his 10-year plan for the NHS, which includes new neighbourhood health centres opening in places where life expectancy is at its lowest. Women made up a disproportionate percentage of those on the waiting list for NHS treatment, at 57%, while also being more likely to be waiting more than 18 and 52 weeks than men. People of a working age (aged between 19 and 64) are also more likely to wait over a year to start treatment, at 3%, compared with 2.5% of those over 65. According to the latest census, 62.9% of the overall population of England and Wales are of working age. Siva Anandaciva, the director of policy, partnerships and events at the King's Fund, said the government's 10-year plan does not say enough on how to reduce health inequalities, and that it is 'simply not ambitious enough'. She added: It is crucial that we see further and faster ambition in the months that come to narrow these avoidable differences in experiences of the NHS. Addressing persistent inequalities in the English health service is ultimately good for patients, good for communities and good for the NHS.' Streeting said: 'Our 10-year health plan will tackle health inequalities faced across the country, diverting billions of pounds to working class communities, and providing truly targeted, bespoke care to all patients where they live via the neighbourhood health service.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store